A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Pfizer
Seagen Inc.
Mayo Clinic
Compass Therapeutics
GlaxoSmithKline
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
Cedars-Sinai Medical Center
Bio-Path Holdings, Inc.
Mundipharma Research Limited
Pfizer
Wake Forest University Health Sciences
Stanford University
University of Nebraska
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Seagen Inc.
Atara Biotherapeutics
Scripps Health
Columbia University
Thomas Jefferson University
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
Northwestern University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
MultiVir, Inc.
Celgene
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison